Cargando…

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Roussin, Isabelle, Parsai, Chirine, Prasad, Sanjay K, Pennell, Dudley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559949/ http://dx.doi.org/10.1186/1532-429X-15-S1-P258

Ejemplares similares

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
por: Natarajan, Arun, et al.
Publicado: (2013)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Comparison of electroanatomic voltage mapping with late gadolinium enhancement CMR
por: Peters, Dana C, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
por: Kotwinski, Paul, et al.
Publicado: (2013)

Exclusion of prognostic coronary disease in LV dysfunction using late gadolinium enhancement CMR
por: Thompson, Alexandra, et al.
Publicado: (2015)

Post-infarction ventricular fibrillation mechanisms: Insights from combined body surface potential mapping and late gadolinium-enhanced CMR
por: Cochet, Hubert, et al.
Publicado: (2016)

Low diagnostic yield of Late Gadolinium Enhancement (LGE) in screening patients with suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) by Cardiovascular Magnetic Resonance (CMR)
por: van Hoorn, Frans, et al.
Publicado: (2012)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

T2-STIR CMR imaging can be used to assess myocardium at risk with gadolinium present in an experimental setting
por: Nordlund, David, et al.
Publicado: (2013)

The utility of free-breathing, motion-corrected late gadolinium enhancement for right ventricular fibrosis imaging in congenital heart disease
por: Heng, Ee Ling, et al.
Publicado: (2015)

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging for cardiomyopathies
por: Morsbach, Fabian, et al.
Publicado: (2014)

Late gadolinium enhancement by cardiovascular magnetic resonance provides prognostic information in symptomatic alcoholic cardiomyopathy
por: Xiangli, Wei
Publicado: (2015)

Improved prediction of adverse events in hypertrophic cardiomyopathy with quantitative late gadolinium enhancement and myocardial strain
por: Brahmanandam, Vikram, et al.
Publicado: (2016)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis
por: Weng, Zhen, et al.
Publicado: (2016)

The early role of CMR in the assessment of cardiomyopathy
por: Barrett, Matthew, et al.
Publicado: (2012)

Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
por: Khan, Tina, et al.
Publicado: (2015)

Left atrial dilation in patients with heart failure and preserved ejection fraction: Value of CMR Simpson method
por: Vassiliou, Vassilis, et al.
Publicado: (2016)

Late Gadolinium Enhancement does occur in the Tako-Tsubo Cardiomyopathy - a quantitative cardiovascular magnetic resonance study
por: Hamilton-Craig, Christian, et al.
Publicado: (2011)

Extent of late gadolinium enhancement in patients with hypertrophic cardiomyopathy in correlation with serum MMP9 as an indicator of myocardial fibrosis
por: Avanesov, Maxim, et al.
Publicado: (2014)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

CMR assessment of hypertrophic cardiomyopathy with restrictive phenotype
por: Lu, Minjie, et al.
Publicado: (2015)

T1 mapping by CMR in patients with arrhythmic cardiomyopathy
por: Zhao, Lei, et al.
Publicado: (2015)

Cardiac effects of anabolic steroid use amongst recreational body builders - a CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Late gadolinium-enhancement cardiovascular magnetic resonance imaging and angiographic characteristics of patients referred for evaluation of new onset cardiomyopathy
por: Danilov, Tatyana, et al.
Publicado: (2011)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
por: Macron, Laurent, et al.
Publicado: (2013)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ilq504dro2m8fb2nuav086fv07